Citadel Advisors’s Innophos Holdings, Inc. IPHS Stock Holding History

Citadel Advisors’s Portfolio IPHS Stock Details IPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,200	Closed	-$201K	–	10127
2019 Q3	$201K	Buy	+6,200	New	+$179K	﹤0.01%	8155
2016 Q1	–	Sell	-5,500	Closed	-$159K	–	8543
2015 Q4	$159K	Buy	5,500 +1,500	+38%	+$52.8K	﹤0.01%	6126
2015 Q3	$159K	Buy	4,000 +1,300	+48%	+$62.9K	﹤0.01%	6439
2015 Q2	$142K	Buy	+2,700	New	+$147K	﹤0.01%	6715
2014 Q3	–	Sell	-1,100	Closed	-$63K	–	8562
2014 Q2	$63K	Buy	1,100 +100	+10%	+$5.45K	﹤0.01%	6590
2014 Q1	$57K	Sell	1,000 -1,000	-50%	-$51.3K	﹤0.01%	6672
2013 Q4	$97K	Buy	2,000 +1,000	+100%	+$49.9K	﹤0.01%	5641
2013 Q3	$53K	Sell	1,000 -5,500	-85%	-$277K	﹤0.01%	5768
2013 Q2	$307K	Buy	+6,500	New	+$336K	﹤0.01%	4283

Other funds holding IPHS

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Citadel Advisors's IPHS Position: Q1 2020 in Review

Citadel Advisors sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 18,893 shares — an estimated $604K sold.

Citadel Advisors first reported a position in IPHS in Q2 2013 and held it in 27 quarters. The position peaked at $4.72M in Q1 2014. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.

Citadel Advisors reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
Citadel Advisors sold 18,893 Innophos Holdings, Inc. shares in Q1 2020, an estimated $604K.
Citadel Advisors first reported a position in Innophos Holdings, Inc. in Q2 2013 and held it in 27 quarters.
Citadel Advisors's Innophos Holdings, Inc. position peaked at $4.72M in Q1 2014.
2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.

Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.